Literature DB >> 29582199

Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study.

Roman Shrestha1,2, Frederick L Altice3,4,5, Pramila Karki6,3, Michael M Copenhaver6,3.   

Abstract

This study reports the feasibility, acceptability, and preliminary efficacy of the bio-behavioral community-friendly health recovery program-an integrated, HIV prevention intervention to improve pre-exposure prophylaxis (PrEP) adherence and HIV-risk reduction behaviors among high-risk people who use drugs. We used a within-subjects, pretest-posttest follow-up design to recruit participants, who were HIV-uninfected, methadone-maintained and reported HIV-risk behaviors and had initiated PrEP (n = 40; males: 55%). Participants were assessed at baseline (T0), immediately post-intervention (4 weeks: T4) and 4 weeks post-intervention (T8). Immediately after completing the four weekly intervention groups, participants underwent a post-intervention assessment including in-depth qualitative interviews. Feasibility was high, assessed by participant willingness to enroll (90.1%) and retention (95%). Results showed that participants were highly satisfied and perceived the intervention as valuable and acceptable [mean: 81.3 (range 0-100)]. Significant enhancements in self-reported PrEP adherence [F(2,74) = 7.500, p = 0.001] and PrEP-related knowledge [F(2,74) = 3.828, p = 0.026] were observed. Drug-related (e.g., injection of drugs, sharing of injection equipment) and sex-related (e.g., number of sexual partners, condomless sex) risk behaviors were reduced, while information, motivation, and behavioral skills (IMB) constructs increased. The results support feasibility and high acceptability and support further examination of the efficacy of this combination bio-behavioral intervention in a prospective clinical trial.

Entities:  

Keywords:  HIV prevention; HIV risk; Methadone maintenance program; People who use drugs; Pre-exposure prophylaxis; Substance abuse

Mesh:

Substances:

Year:  2018        PMID: 29582199      PMCID: PMC6051885          DOI: 10.1007/s10461-018-2099-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  32 in total

1.  Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment.

Authors:  Roman Shrestha; Pramila Karki; Frederick L Altice; Tania B Huedo-Medina; Jaimie P Meyer; Lynn Madden; Michael Copenhaver
Journal:  Drug Alcohol Depend       Date:  2017-02-02       Impact factor: 4.492

2.  HIV and risk environment for injecting drug users: the past, present, and future.

Authors:  Steffanie A Strathdee; Timothy B Hallett; Natalia Bobrova; Tim Rhodes; Robert Booth; Reychad Abdool; Catherine A Hankins
Journal:  Lancet       Date:  2010-07-24       Impact factor: 79.321

3.  Examining the Acceptability of mHealth Technology in HIV Prevention Among High-Risk Drug Users in Treatment.

Authors:  Roman Shrestha; Tania B Huedo-Medina; Frederick L Altice; Archana Krishnan; Michael Copenhaver
Journal:  AIDS Behav       Date:  2017-11

Review 4.  Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence.

Authors:  Seth M Noar
Journal:  AIDS Behav       Date:  2007-09-21

5.  Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

Authors:  S Kelly Avants; Arthur Margolin; Mary Helen Usubiaga; Cheryl Doebrick
Journal:  J Subst Abuse Treat       Date:  2004-03

6.  Assessing treatment acceptance: the Abbreviated Acceptability Rating Profile.

Authors:  K J Tarnowski; S J Simonian
Journal:  J Behav Ther Exp Psychiatry       Date:  1992-06

Review 7.  Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches.

Authors:  Jennifer L Brown; Jessica M Sales; Ralph J DiClemente
Journal:  Curr HIV/AIDS Rep       Date:  2014-12       Impact factor: 5.071

8.  High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study.

Authors:  Mark J Siedner; Jessica E Haberer; Mwebesa Bosco Bwana; Norma C Ware; David R Bangsberg
Journal:  BMC Med Inform Decis Mak       Date:  2012-06-21       Impact factor: 2.796

9.  Pre-exposure prophylaxis and the promise of combination prevention approaches.

Authors:  Susan P Buchbinder; Albert Liu
Journal:  AIDS Behav       Date:  2011-04

10.  PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives.

Authors:  Anya Y Spector; Robert H Remien; Susan Tross
Journal:  Subst Abuse Treat Prev Policy       Date:  2015-01-08
View more
  18 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.

Authors:  Angela R Bazzi; Dea L Biancarelli; Ellen Childs; Mari-Lynn Drainoni; Alberto Edeza; Peter Salhaney; Matthew J Mimiaga; Katie B Biello
Journal:  AIDS Patient Care STDS       Date:  2018-10-11       Impact factor: 5.078

3.  Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).

Authors:  Roman Shrestha; Michael M Copenhaver
Journal:  Addict Behav       Date:  2018-05-31       Impact factor: 3.913

4.  The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.

Authors:  Suzan M Walters; Bethany Coston; Alan Neaigus; Alexis V Rivera; Lila Starbuck; Valentina Ramirez; Kathleen H Reilly; Sarah L Braunstein
Journal:  Int J Drug Policy       Date:  2020-02-21

5.  HIV Pre-Exposure Prophylaxis Prevention Awareness, Willingness, and Perceived Barriers among People Who Inject Drugs in Los Angeles and San Francisco, CA, 2016-2018.

Authors:  Suzan M Walters; Alex H Kral; Kelsey A Simpson; Lynn Wenger; Ricky N Bluthenthal
Journal:  Subst Use Misuse       Date:  2020-09-23       Impact factor: 2.164

6.  Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: The key role of non-medical staff in enhancing HIV prevention.

Authors:  J Jaiswal; K Dunlap; M Griffin; A Cox; S N Singer; K Hascher; C LoSchiavo; S M Walters; M Mumba
Journal:  J Subst Abuse Treat       Date:  2021-03-17

7.  Exploring the Use of Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among High-Risk People Who Use Drugs in Treatment.

Authors:  Roman Shrestha; Michael Copenhaver
Journal:  Front Public Health       Date:  2018-07-13

8.  The Role of Alcohol-Related Behavioral Risk in the Design of HIV Prevention Interventions in the Era of Antiretrovirals: Alcohol Challenge Studies and Research Agenda.

Authors:  William H George; Jessica A Blayney; Cynthia A Stappenbeck; Kelly Cue Davis
Journal:  AIDS Behav       Date:  2021-07-09

9.  The Pre-exposure Prophylaxis (PrEP) Care Cascade in People Who Inject Drugs: A Systematic Review.

Authors:  Colleen B Mistler; Michael M Copenhaver; Roman Shrestha
Journal:  AIDS Behav       Date:  2021-05

10.  Performance of a short, self-report adherence scale in a probability sample of persons using HIV antiretroviral therapy in the United States.

Authors:  Ira B Wilson; Yunfeng Tie; Mabel Padilla; William H Rogers; Linda Beer
Journal:  AIDS       Date:  2020-12-01       Impact factor: 4.632

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.